...
Maven
New MDR Certification Process

Team-NB’s New MDR Certification Process Guidance: What Medical Device Manufacturers Need to Know

The MDR certification landscape continues to evolve as Notified Bodies seek greater consistency in how they interpret and apply Regulation (EU) 2017/745 (MDR). The newly released Team-NB Position Paper (Version 2, June 2026) supports a more harmonized certification approach.

Although the document does not introduce new legal requirements, it provides practical guidance on how certification activities are expected to be conducted throughout the certification lifecycle; from the first interaction with a Notified Body to post-certification surveillance activities.

For manufacturers, this reinforces that MDR certification is not a one-time approval but an ongoing regulatory process that extends beyond certification into post-market activities.

Why This Guidance Matters

What if a well-prepared MDR submission still faces delays due to differing Notified Body expectations?

Variations in application requirements, documentation expectations and assessment approaches can create uncertainty for manufacturers. The Team-NB consensus document seeks to address these challenges by aligning expectations across key stages of the conformity assessment process, supporting more consistent, efficient, and predictable MDR certification.

MDR Certification Is a Multi-Stage Lifecycle Process

MDR Certification Is a Multi-Stage Lifecycle Process

The MDR certification process follows a structured pathway that enables manufacturers to demonstrate compliance with Regulation (EU) 2017/745 before placing devices on the European market.

1. Initial Contact & Pre-Application Submission

Purpose: Establish communication with the Notified Body (NB) and define the certification scope.

  • Submission of preliminary device and company information.
  • Preliminary review of MDR applicability and device classification.
  • Manufacturers or EU Representatives must submit the required Annex A information to enable the Notified Body to prepare a conformity assessment quotation.

2. Pre-Application Review & Quotation Process

Purpose: Enable the NB to evaluate the project scope, complexity, and assessment requirements.

  • Verification of MDR scope and device classification.
  • Review of manufacturer, site, supplier, and product information.
  • Clarification of missing or incomplete information.
  • Issuance of a quotation for conformity assessment services.

3. Formal Application Submission

Purpose: Officially initiate the MDR certification process.

  • Submission of Quality Management System (QMS) documentation.
  • Submission of technical and regulatory documentation.
  • Justification of Medical Device intended purpose, qualification and classification.
  • Formal lodging of the certification application.

Note: Legacy devices transitioning under MDR may submit a technical documentation plan rather than the complete technical file at this stage.

4. Contract/Written Agreement & Application Review

Purpose: Confirm the application’s completeness and suitability for assessment.

  • Establishment of a contract or written agreement.
  • Review of application completeness.
  • Verification of the selected conformity assessment route.
  • Application acceptance or rejection.

5. Conformity Assessment

Purpose: Demonstrate compliance with MDR safety, performance, and quality requirements.

  • QMS audits.
  • Technical Documentation Assessment (TDAR).
  • Clinical Evaluation Assessment (CEAR).
  • Product testing and verification, where applicable.
  • Additional consultations for specific device categories.

6. Final Review & Certification Decision

Purpose: Confirm that all MDR requirements have been successfully met.

  • Independent review of assessment outcomes.
  • Verification of corrective actions and non-conformity closure.
  • Review of post-market surveillance arrangements.
  • Certification approval or refusal.

7. Certificate Issuance

Purpose: Formally certify the device’s compliance with MDR requirements.

  • Issuance of the MDR certificate.
  • Registration of certification details in EUDAMED.
  • Confirmation of compliance with Regulation (EU) 2017/745.
  • Authorization to continue placing the device on the EU market.

8. Surveillance

Purpose: Ensure continued compliance throughout the certificate lifecycle.

  • Periodic surveillance audits.
  • Review of vigilance reports and PSURs.
  • Assessment of significant device or QMS changes.
  • Technical documentation sampling.
  • Unannounced audits, where applicable.

MDR certification is not a one-time event. Manufacturers must continuously demonstrate compliance throughout the validity of the certificate.

Data Readiness: A Critical MDR Requirement

The Team-NB guidance emphasizes that MDR certification starts with strong data readiness. Manufacturers should maintain accurate and up-to-date information on:

  • Company and site details
  • SRN and PRRC information
  • Suppliers and subcontractors
  • Device classification, intended purpose, and Basic UDI-DI
  • EMDN/MDR codes and sterilization details
  • Existing certifications and technical documentation plans

Regulatory Takeaways

The guidance reinforces several important MDR expectations:

  • Certification readiness begins before formal application.
  • Data quality directly impacts assessment timelines.
  • Legacy devices may rely on structured documentation plans during transition.
  • Post-market surveillance is a continuous responsibility.
  • Effective change management is essential for maintaining compliance.

What Manufacturers Should Do

To improve certification readiness, manufacturers should focus on:

  • Strengthening pre-application data quality.
  • Confirming device classification and intended purpose.
  • Maintaining robust supplier and site documentation.
  • Planning MDR technical documentation activities early.
  • Strengthening PMS, PMCF, and vigilance processes.
  • Implementing formal change control procedures.

Conclusion

While the Team-NB Position Paper does not introduce new MDR requirements, it provides valuable insight into how Notified Bodies are expected to apply them in practice.

The overarching message is clear: successful MDR certification depends on data readiness, proactive planning, and continuous compliance throughout the device lifecycle.

Reference

1. MDR Certification Process (including Pre-application, Application and Post Application phases) – Consensus document

Frequently Asked Questions

The Team-NB MDR Certification Process Guidance is a consensus document developed by Team-NB to promote a more consistent approach among Notified Bodies when assessing medical devices under Regulation (EU) 2017/745 (MDR). While it does not introduce new legal requirements, it clarifies how certification activities are expected to be performed throughout the entire certification lifecycle.

No. The guidance does not create new regulatory obligations. Instead, it explains how existing MDR requirements should be applied consistently by Notified Bodies during pre-application, conformity assessment, certification, and post-certification surveillance.

Accurate and complete pre-application information helps Notified Bodies determine project scope, prepare quotations, verify device classification, and reduce delays during the conformity assessment process. High quality data can significantly improve certification efficiency.

A Notified Body independently assesses whether a medical device and the manufacturer’s Quality Management System comply with the requirements of Regulation (EU) 2017/745. It performs audits, technical documentation reviews, clinical evaluations, and surveillance activities before issuing and maintaining MDR certificates.

The guidance improves consistency between Notified Bodies by providing common expectations for certification activities. This helps manufacturers better prepare applications, reduce uncertainty, and improve certification readiness.